Friday, July 10, 2026

pharma

STADA Pharmaceuticals Australia

STADA Pharmaceuticals Australia drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

AU HQ
TGA registrant Type
Company details
Status
Public
HQ
AU
Programs
0
Drugs
1
Patents
0
Intelligence · Drug Pipeline

STADA Pharmaceuticals Australia pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

STADA Pharmaceuticals Australia drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. apomorphine

    Genito-urinary system and sex hormones (G04)

    Genito-urinary system and sex hormones (G04) compound in STADA Pharmaceuticals Australia's portfolio. Mechanism: D2-like dopamine receptor agonist.

    Mechanism
    D2-like dopamine receptor agonist